Clinical Trial Update: MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C [Phase 1]

View source ↗

Summary

Phase 1 trial update of MLN0264 in previously treated Asian patients with advanced gastrointestinal carcinoma, including gastric and gastroesophageal junction a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma
• Gastrointestinal Carcinoma

Drugs mentioned

• MLN0264

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Advanced Gastrointestinal Carcinoma, Gastroesophageal Junction Adenocarcinoma | Phase 1 | Status: TERMINATED | Results posted: 2017-03-29